Choreo LLC’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$781K Buy
9,886
+2,205
+29% +$187K 0.01% 764
2026
Q1
$660K Buy
7,681
+353
+5% +$31.7K 0.01% 802
2025
Q4
$643K Buy
7,328
+85
+1% +$6.45K 0.01% 809
2025
Q3
$415K Sell
7,243
-797
-10% -$45.9K 0.01% 1027
2025
Q2
$475K Buy
8,040
+2,449
+44% +$158K 0.01% 918
2025
Q1
$409K Sell
5,591
-3,693
-40% -$305K 0.01% 933
2024
Q4
$768K Buy
9,284
+716
+8% +$56.5K 0.01% 680
2024
Q3
$603K Buy
8,568
+957
+13% +$67.6K 0.01% 811
2024
Q2
$517K Buy
+7,611
New +$455K 0.01% 792

Other funds holding GMED

Choreo LLC's GMED Position: Q2 2026 in Review

Choreo LLC increased its Globus Medical (GMED) stake by 29% in Q2 2026, buying an estimated $187K and bringing the position to 9,886 shares worth $781K. The position accounts for 0.01% of the portfolio, ranked #764.

Choreo LLC first reported a position in GMED in Q2 2024 and has held it in 9 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Choreo LLC held 9,886 shares of Globus Medical worth $781K as of Q2 2026.
  • Choreo LLC bought 2,205 Globus Medical shares in Q2 2026, an estimated $187K.
  • Globus Medical made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #764 holding.
  • Choreo LLC first reported a position in Globus Medical in Q2 2024 and has held it in 9 quarters since.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.